Breast cancer risk in women who have had children with different partners

被引:3
作者
Lambe, M
Rossing, MA
Wuu, J
Hsieh, CC
机构
[1] Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden
[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[3] Univ Massachusetts, Ctr Canc, Worcester, MA 01605 USA
关键词
breast cancer; parity; childbearing; fetal antigens; Sweden;
D O I
10.1002/ijc.1414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The fetal antigen hypothesis suggests that the lowered risk of breast cancer in parous women may be afforded by the development of antibodies to fetal antigens that are structurally similar to mammary cancer antigens. It has previously been hypothesized that the likelihood of developing such antibodies may be higher among women who have had children with more than 1 partner. Utilizing information on parenthood and breast cancer available in nationwide Swedish registers, we undertook a case-control study nested within a nation-wide cohort to address this issue. Number of partners fathering a child was categorized as 1, 2 and 3 or more. All analyses were restricted to subjects with 2 or more births and encompassed a total of 20,881 women with breast cancer and 111,989 control women. In an unadjusted analysis, the risk of breast cancer was somewhat lower (odds ratio [OR] = 0.94, 95% confidence interval [CI] 0.89-0.99) in women who had had children with 2 different partners compared with women who had had children conceived with the same partner. After adjustment for parity, age at first birth and educational level, however, the risk of breast cancer was slightly elevated (OR = 1.09, 95% Cl: 1.03-1.15). Among women who had had children with 3 or more different men, the pattern was similar. The present results provide no support for the hypothesis that greater antigenic exposure afforded by having children with more than I man may reduce the risk of breast cancer. It remains possible, however, that pregnancy may influence breast cancer risk through some immunologic mechanism; further testing of the fetal antigen hypothesis may require development of relevant laboratory measures. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:907 / 910
页数:4
相关论文
共 16 条
[1]  
AGRAWAL B, 1995, CANCER RES, V55, P2257
[2]  
Agrawal B, 1996, J IMMUNOL, V157, P2089
[3]  
Botelho F, 1998, AM J REPROD IMMUNOL, V39, P279
[4]   Disturbed feto-maternal cell traffic in preeclampsia [J].
Holzgreve, W ;
Ghezzi, F ;
Di Naro, E ;
Gänshirt, D ;
Maymon, E ;
Hahn, S .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (05) :669-672
[5]  
Hsieh CC, 1999, INT J CANCER, V81, P335, DOI 10.1002/(SICI)1097-0215(19990505)81:3<335::AID-IJC4>3.0.CO
[6]  
2-L
[7]   THE FETAL ANTIGEN HYPOTHESIS FOR BREAST-CANCER, REVISITED [J].
JANERICH, DT .
MEDICAL HYPOTHESES, 1994, 43 (02) :105-110
[8]   THE INFLUENCE OF PREGNANCY ON BREAST-CANCER RISK - IS IT ENDOCRINOLOGICAL OR IMMUNOLOGICAL [J].
JANERICH, DT .
MEDICAL HYPOTHESES, 1980, 6 (11) :1149-1155
[9]   REDUCED BREAST-CANCER RISK AFTER REMARRIAGE - EVIDENCE OF GENETIC IMMUNE PROTECTION [J].
JANERICH, DT ;
THOMPSON, WD .
EPIDEMIOLOGY, 1995, 6 (03) :254-257
[10]   Microchimerism and HLA-compatible relationships of pregnancy in scleroderma [J].
Nelson, JL ;
Furst, DE ;
Maloney, S ;
Gooley, T ;
Evans, PC ;
Smith, A ;
Bean, MA ;
Ober, C ;
Bianchi, DW .
LANCET, 1998, 351 (9102) :559-562